Mayfair Pharmaceuticals Limited
09045376
Healthy
- No accounts filed in last 18 months (-5)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/03/2025
unaudited abridged
Next accounts due
31/12/2026
Confirmation statement
Last: 13/08/2025
Due 27/08/2026
Industry
Officers
Persons with Significant Control
Mr Nariman Akrami
British · England · Age 40
34, South Molton Street, London, W1K 5RG
Notified 08/04/2016
Former PSCs
Mr Nariman Akrami
Ceased 01/06/2019
Charges1 outstanding
SELLERSFUNDING INTERNATIONAL PORTFOLIO LTD
CompanyRankvs 4142+ SIC 47910 peers71
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£174k
Balance sheet strength
Cash
£169k
Cash in the bank
Net Current Assets
£254k
Working capital
Current Assets
£711k
Current Liabilities
£458k
Fixed Assets
£7k
Debtors
£479k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.55 | +£34k |
| 2024 | 1.29 | -£21k |
| 2023 | 1.61 | — |
Derived from filed accounts. Not audited figures.